Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04403919 · ClinicalTrials.gov registry record · NA
Knotless Suture in Revision Total Joint Arthroplasty
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 81
- Enrollment target
NCT04403919: Completed NA study, sponsored by NYU Langone Health.
NCT04403919 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 81 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04403919, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
Study Summary
Barbed suture has been demonstrated to be safe in primary hip and knee surgery and retrospective data suggests barbed suture represents no increased complications in the revision setting. Barbed suture may represent a faster, more effective way to perform revision arthroplasty closures. There are no Level I studies comparing traditional and barbed suture closure. The purpose of this study is to assess the surgical complexities of closures using closure time without sacrificing cosmesis or wound complications between the traditional closure and barbed closure.
Primary Outcome
Measurement of the time needed to properly close the wound with each technique.
Interventions
- DEVICE Conventional Closure: Knee
- DEVICE Barbed suture closure: Knee
- DEVICE Conventional Closure: Hip
- DEVICE Barbed suture closure: Hip
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2023-06-01 |
| Phase | NA |
What the finished NCT04403919 record still lists
NCT04403919 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 81 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 4 interventions - of which Conventional Closure: Knee is the first listed.
NCT04403919 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04403919 about?
NCT04403919 is a clinical study titled "Knotless Suture in Revision Total Joint Arthroplasty". Barbed suture has been demonstrated to be safe in primary hip and knee surgery and retrospective data suggests barbed suture represents no increased complications in the revision setting. Barbed suture may represent a faster, more effective way to perform revision arthroplasty closures. There are no...
What is the current status of trial NCT04403919?
This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2020-09-01. Estimated completion is 2023-06-01.
What interventions are being tested in trial NCT04403919?
The interventions under investigation include: Conventional Closure: Knee (DEVICE), Barbed suture closure: Knee (DEVICE), Conventional Closure: Hip (DEVICE), Barbed suture closure: Hip (DEVICE).
Who is sponsoring clinical trial NCT04403919?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04403919's enrollment target sits among peer trials
81 992nd of 2000 higher than 1,007 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI